BioAge Labs
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -22,981 | -13,089 | -11,742 | -18,358 |
EBIT | -23,019 | -13,138 | -11,775 | -18,399 |
Net Income | -23,407 | -13,581 | -12,992 | -20,958 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -15,236 | -15,816 | -15,672 | -8,503 |
Cash | 334,474 | 159,085 | 173,992 | 21,644 |
Basic Shares | 3,494 | 33,667 | 33,667 | 11,807 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $14,942 | $8,272 |
Gross Profit | -7,380 | -5,394 | ||
EBITDA | -45,807 | -39,375 | -88,723 | -13,290 |
EBIT | -45,969 | -39,504 | -98,069 | -22,452 |
Net Income | -63,854 | -39,722 | -98,151 | -22,478 |
Net Change In Cash | 0 | 0 | 14,942 | 8,272 |
Free Cash Flow | -37,528 | -36,284 | -29,789 | -37,615 |
Cash | 21,644 | 27,644 | 4,631 | 16,160 |
Basic Shares | 33,667 | 33,667 | 41,948 | 34,191 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.68 |
